ONACTIO Canadian Trademark Information
Pharmaceutical preparations for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, namely, central nervous system infections, brain diseases, central nervous system movement disorders, depression, Alzheimer's and Parkinson's disease, respiratory diseases, cancer, allergies, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, namely respiratory infections and eye infections, eye diseases, dermatological diseases, namely dermatitis, skin pigmentation diseases and sexually transmitted diseases, autoimmune diseases, blood diseases, genital diseases, namely urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic disease, endocrine diseases, namely growth and thyroid disorders, intestinal diseases, internal medicine diseases, namely respiratory diseases; hormones for medical purposes, vitamins, dietetic and food substances adapted for medical use, namely dietetic food and supplements for medical use for the prevention and treatment of respiratory diseases.
Perfect for these industries
Words that describe this mark
pharmaceutical preparations treatment cardiovascular diseases central peripheral nervous diseases central nervous infections brain diseases central nervous movement disorders depression alzheimers parkinsons disease respiratory diseases cancer allergies
Abandonment Notice!
On Tuesday, December 12, 2017,
status on the ONACTIO
trademark changed to Application withdrawn.
Apply Now for this name starting at $449!
CAUTION: Although Canada registration for this particular filing is inactive,
the mark may still enjoy common law rights, or may have been applied for again in a separate application.
Further research may be warranted to determine where this mark is truly abandoned in commerce.
On Friday, May 8, 2015, a canadian trademark registration was filed for
ONACTIO by SANOFI *********, **********, ***** ****.
The Canadian IP office has given the trademark application number of
1727363.
The current status of this trademark filing is Application withdrawn.
The correspondent listed for
ONACTIO is
BERESKIN & PARR LLP/S.E.N.C.R. of *********, **********, ***** ****
The ONACTIO
trademark is filed in the description of
Pharmaceutical preparations for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, namely, central nervous system infections, brain diseases, central nervous system movement disorders, depression, Alzheimer's and Parkinson's disease, respiratory diseases, cancer, allergies, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, namely respiratory infections and eye infections, eye diseases, dermatological diseases, namely dermatitis, skin pigmentation diseases and sexually transmitted diseases, autoimmune diseases, blood diseases, genital diseases, namely urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic disease, endocrine diseases, namely growth and thyroid disorders, intestinal diseases, internal medicine diseases, namely respiratory diseases; hormones for medical purposes, vitamins, dietetic and food substances adapted for medical use, namely dietetic food and supplements for medical use for the prevention and treatment of respiratory diseases.
.
100% Satisfaction Guarantee
protect your valuable brand now.
Classification Information